Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001248247 | SCV001421718 | pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 2022-02-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 972257). This variant is also known as Trp-29->term. This premature translational stop signal has been observed in individual(s) with protein C deficiency (PMID: 8462980). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp14*) in the PROC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PROC are known to be pathogenic (PMID: 17152060). |
Mayo Clinic Laboratories, |
RCV003481033 | SCV004226451 | likely pathogenic | not provided | 2022-07-13 | criteria provided, single submitter | clinical testing | PM2, PVS1 |
ISTH- |
RCV002245902 | SCV002515553 | pathogenic | Reduced protein C activity | no assertion criteria provided | research |